Opioid antagonists and drinking: evidence of kappa-receptor involvement.

Abstract

Diprenorphine, naloxone, MR-2266-BS and WIN-44,441-3 were compared for their ability to antagonize morphine analgesia and to decrease deprivation-induced drinking in rats. Diprenorphine and naloxone were markedly more potent (32x) than MR-2266-BS and WIN-44,441-3 in antagonizing the analgesic effects of morphine. In contrast, diprenorphine, naloxone and MR-2266-BS decreased deprivation-induced drinking over a similar dose range. The doses required to reduce fluid consumption were higher than those necessary to antagonize morphine. WIN-44,441-3 was ineffective in decreasing drinking. The relatively similar potencies of diprenorphine, naloxone and MR-2266-BS for decreasing deprivation-induced drinking suggest that the effect on drinking involves antagonist activity at a kappa-opioid receptor.

Statistics

020004000'86'89'92'95'98'01'04'07'10'13'16
Citations per Year

637 Citations

Semantic Scholar estimates that this publication has 637 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Leander1983OpioidAA, title={Opioid antagonists and drinking: evidence of kappa-receptor involvement.}, author={J. David Leander and Martin D. Hynes}, journal={European journal of pharmacology}, year={1983}, volume={87 4}, pages={481-4} }